Benz, E
[PMID: 28828619] PubMed record related to this compound for laboratory literature review
Taking it too close to your next dose increases the risk of side effects
When both are active simultaneously, the combined effect on metabolism, body composition, and heart rate demands closer clinical monitoring than either therapy alone
Anti-obesity medicines, based around incretin receptor agonists and their novel combination with other appetite regulatory targets, have weight reduction efficacy in this population, addressing obesity-related cardiometabolic complications while preserving skeletal muscle mass
Short-term plateaus can occur because of water retention, digestion, sodium intake, hormonal changes, physical activity, body-composition changes, or normal variation